Terms: = Breast cancer AND MDM4, DKFZp781B1423, 4194, ENSG00000198625, RP11-430C7_1, MRP1, MDMX, MGC132766 AND Treatment
47179 results:
1. Exogenous Metabolic Modulators Improve Response to Carboplatin in Triple-Negative breast cancer.
Ho AN; Kiesel VA; Gates CE; Brosnan BH; Connelly SP; Glenny EM; Cozzo AJ; Hursting SD; Coleman MF
Cells; 2024 May; 13(10):. PubMed ID: 38786030
[TBL] [Abstract] [Full Text] [Related]
2. Efficacy and safety of eribulin mesylate in patients with locally advanced or metastatic breast cancer previously treated with anthracycline/taxanes.
Chen L; Yan X; Luo T; Tian T; He P; Zhong X
Cancer Med; 2024 May; 13(10):e7295. PubMed ID: 38785215
[TBL] [Abstract] [Full Text] [Related]
3. Identification of restrictive molecules involved in oncolytic virotherapy using genome-wide CRISPR screening.
Zhong Y; Le H; Zhang X; Dai Y; Guo F; Ran X; Hu G; Xie Q; Wang D; Cai Y
J Hematol Oncol; 2024 May; 17(1):36. PubMed ID: 38783389
[TBL] [Abstract] [Full Text] [Related]
4. Systematic literature review of real-world evidence for treatments in HR+/HER2- second-line LABC/mBC after first-line treatment with CDK4/6i.
Lambert V; Kane S; Howidi B; Nguyen BN; Chandiwana D; Wu Y; Edwards M; Samjoo IA
BMC Cancer; 2024 May; 24(1):631. PubMed ID: 38783218
[TBL] [Abstract] [Full Text] [Related]
5. [Feasibility analysis of the application of programmed process endoscopic lateral neck dissection via chest-breast approach in papillary thyroid carcinoma surgery].
Xu N; Li ZY; Luo XP; Gao HY; Huang JF; Wang YY; Liu XJ; Xu B
Zhonghua Yi Xue Za Zhi; 2024 May; 104(20):1831-1836. PubMed ID: 38782751
[No Abstract] [Full Text] [Related]
6. cancer treatment Before and After Physician-Pharmacy Integration.
Kanter GP; Ozluk P; Chi W; Fisch MJ; Debono D; Parikh RB; Jacobson M; Bekelman JE; DeVries A
JAMA Netw Open; 2024 May; 7(5):e2412998. PubMed ID: 38780938
[TBL] [Abstract] [Full Text] [Related]
7. Local intralesional talimogene laherparepvec therapy with complete local response in oral palatine mucosal melanoma: a case report.
Chitnis SD; Seim NB; Kendra K
J Med Case Rep; 2024 May; 18(1):257. PubMed ID: 38778387
[TBL] [Abstract] [Full Text] [Related]
8. Patterns of care at the end of life: a retrospective study of Italian patients with advanced breast cancer.
Giannubilo I; Battistuzzi L; Blondeaux E; Ruelle T; Poggio FB; Buzzatti G; D'Alonzo A; Della Rovere F; Latocca MM; Molinelli C; Razeti MG; Nardin S; Arecco L; Perachino M; Favero D; Borea R; Pronzato P; Del Mastro L; Bighin C
BMC Palliat Care; 2024 May; 23(1):129. PubMed ID: 38778303
[TBL] [Abstract] [Full Text] [Related]
9. [Adequacy of provision of procedures for early detection of breast cancer in the Brazilian Unified National Health System: a cross-sectional study conducted in Brazil and its regions, 2019].
Dias MBK; Assis M; Santos ROMD; Ribeiro CM; Migowski A; Tomazelli JG
Cad Saude Publica; 2024; 40(5):e00139723. PubMed ID: 38775611
[TBL] [Abstract] [Full Text] [Related]
10. Assessment of Radiation Induced Pneumonitis and Pericarditis in Patients Undergoing breast Conservative treatment Using Hypofractionated Simultaneous Integrated Boost Technique.
Sundaramoorthy S; Karunanidhi G; Pal P; C SV; Radhakrishnan H
Gulf J Oncolog; 2024 May; 1(45):15-29. PubMed ID: 38774929
[TBL] [Abstract] [Full Text] [Related]
11. Prophylactic central lymph node dissection in cN0 papillary thyroid cancer: a comparative study of via breast and transoral approach versus via breast approach alone.
Qiu R; Fu J
Front Endocrinol (Lausanne); 2024; 15():1356739. PubMed ID: 38774230
[TBL] [Abstract] [Full Text] [Related]
12. Infrared laser moxibustion for cancer-related fatigue in breast cancer survivors: a randomized controlled trial.
Mao H; Jin M; Xie L; Mao N; Shen X; Chen J; Chen X; Mao JJ; Shen X
Breast Cancer Res; 2024 May; 26(1):80. PubMed ID: 38773552
[TBL] [Abstract] [Full Text] [Related]
13. Integrated analysis of single-cell and bulk RNA sequencing data reveals a myeloid cell-related regulon predicting neoadjuvant immunotherapy response across cancers.
Liu H; Sima X; Xiao B; Gulizeba H; Zhao S; Zhou T; Huang Y
J Transl Med; 2024 May; 22(1):486. PubMed ID: 38773508
[TBL] [Abstract] [Full Text] [Related]
14. Surgical outcomes of robotic thyroidectomy for thyroid tumors over 4 cm via the bilateral axillo-breast approach.
Bae HL; Wong JS; Kim SJ; Jung Y; Choi JB; Kwak J; Yu HW; Chai YJ; Choi JY; Lee KE
Sci Rep; 2024 May; 14(1):11646. PubMed ID: 38773181
[TBL] [Abstract] [Full Text] [Related]
15. An assessment of the direct and indirect costs of breast cancer treatment in leading cancer hospitals in Ghana.
Okyere Asante PG; Owusu AY; Oppong JR; Amegah KE; Nketiah-Amponsah E
PLoS One; 2024; 19(5):e0301378. PubMed ID: 38771827
[TBL] [Abstract] [Full Text] [Related]
16. Abemaciclib plus endocrine therapy versus chemotherapy after progression on prior palbociclib in HR+/HER2- metastatic breast cancer: A single center real-world study in China.
Jiang H; Zhong J; Wang J; Song G; Di L; Shao B; Zhang R; Liu Y; Zhu A; Wang N; Li H
Cancer Med; 2024 May; 13(10):e7249. PubMed ID: 38770648
[TBL] [Abstract] [Full Text] [Related]
17. Survival Predictive Nomograms for Non-Surgical Brain Metastases Patients From Non-Small Cell Lung cancer Receiving Radiotherapy: A Population-Based Study.
Li P; Luo J; Zheng Z; Meng L; Zhang A; Cao W; Gong X
Cancer Control; 2024; 31():10732748241255212. PubMed ID: 38769789
[TBL] [Abstract] [Full Text] [Related]
18. Autologous fat transplantation prior to permanent expander implant breast reconstruction enhances the outcome after two years: a randomized controlled trial.
Lindegren A; Schultz I; Edsander-Nord Å; Yan J; Wickman M
J Plast Surg Hand Surg; 2024 May; 59():65-71. PubMed ID: 38769740
[TBL] [Abstract] [Full Text] [Related]
19. Guidelines for the clinical application of the
Tang H; Lu Q; Feng S; Xiao Z; Wu W; Chen G; Deng L; Yu T; Wu J; Lin H; Ji B; Lin J; Zhang C; Li L; Liu T; Ouyang Y; Lei K; Chen J; Peng W; Qiu Z; Cai Q; Liang Q; Liu C; Li Y; Zhu L; Zhang Z; Liu X; Lin L; Zheng Z
Pharm Biol; 2024 Dec; 62(1):472-479. PubMed ID: 38769628
[TBL] [Abstract] [Full Text] [Related]
20. Proteomic characterization and cytotoxic potential of proteins from Cuscuta (Cuscuta epithymum (L.) crude herbal product against MCF-7 human breast cancer cell line.
Akhtar U; Khurshid Y; El-Aarag B; Syed B; Khan IA; Parang K; Ahmed A
BMC Complement Med Ther; 2024 May; 24(1):195. PubMed ID: 38769554
[TBL] [Abstract] [Full Text] [Related]
[Next]
